第二届“百名海外名校博士创业中国行”活动通知

为落实党的十八大、十八届三中全会关于实施创新驱动发展战略,响应国家“大众创业,万众创新”的号召,深入贯彻习近平总书记在欧美同学会成立100周年庆祝大会上的讲话及 2016年5月中共中央办公厅印发的《关于加强欧美同学会(留学人员联谊会)建设的意见》精神,发挥我会特点和优势,为实现中华民族伟大复兴“中国梦”服务。欧美同学会定于12月18日至24日在北京、广州、宁波举办第二届“百名海外名校博士创业中国行”活动。该活动在广州部分已经列为2016中国海外人才交流大会暨第十八届中国留学人员广州科技交流会活动主要内容之一。

详细活动方案及报名表等信息见附件。本次活动的报名截止日期为2016年11月30日,请及时将报名表发送到工作邮箱。会议组织方将承担您参加本次活动的交通食宿费用。

请将报名表发送至:wrsaphd@163.com

联 系 人:朱宁新

联系电话:01065122800/18810111769

联系微信:wrsa-cosa

校友职业发展交流讲座系列第四期​—生物医药行业机会分析与职业发展规划

近期到来的年轻校友们希望能多了解各行业状况和市场形势,也渴望在如何规划职业发展,培养职场能力,找到理想的工作等方面得到指导和建议。应校友们的需求,多所大学校友会联合学生组织共同举办系列职业发展交流讲座来促进校友间的职业经验与智慧的分享交流,帮助年轻校友职业发展,加深校友间的紧密联系,让大家共同进步。

生物医药行业近些年发展迅速,中美医药行业的广泛合作也促进了中国生物医药也的快速进步,所以在美国和中国生物医药各领域机会很多,但竞争也很激烈。如何在生物医药业取得一席之地,并成功驾驭职业发展是众多校友们关注的话题。我们将生物医药行业机会分析和职业发展规划作为主题来做第四期讲座。为此我们邀请到了几位生物医药领域经验丰富的专家和最近刚成功找到工作的校友来给大家做分享和互动交流。

他们的专业领域覆盖生物医药研发,临床实验,项目管理,生物统计,专利申报,以及对外合作和项目引进等。特邀分享嘉宾包括:

Frank Gan         Director, Clinical Research, Johnson & Johnson

Jimmy Hao       Attorney at Law and registered US Patent Attorney, FoxRothschild LLC

Guanghui Hu President and CEO, Admera Health

Mike Hu Senior Director, Clinical Development, Jazz Pharmaceuticals

Jerry Jing Li       Associate Principal Scientist, Global Clinical Development, Merck

Jian Liu Principal Scientist, External Discovery Chemistry, Merck

John Sun           Global Project Manager, Novartis (Moderator)

Bing Yuan         Executive Director, Oncology Business Development, Merck

时间:11/19日,星期六,下午2点到6点

地点:701 West 168th Street, Hammer Health Sciences Building, Room 401, New York, NY 10032

费用:$10 (提供饮料和snacks)

注册:因场地位置有限,请务必用此链接注册

https://www.eventbrite.com/e/29302735270

主办单位:武汉大学大纽约地区校友会,北京大学大纽约地区校友会,大纽约地区清华校友会,天津大学(北洋大学)北美校友会, 北美浙江大学校友会大纽约分会,华中科技大学大纽约校友会,中国科技大学大纽约校友会, 南京大学大纽约校友会,复旦大学美国校友会纽约分会,纽约南开校友会,中央财经大学美国校友会,交通大学美洲校友会大纽约分会,美中医药开发协会(SAPA)

协办单位:哥伦比亚大学医学院中国学生学者联谊会

嘉宾简介:

Frank Gan, Pharm. D.

Clinical Research Director

Oncology Department, Johnson & Johnson

Frank is a clinical research director working at Janssen Oncology Department. He was a bench scientist with experiences working in both academic and biopharmaceutical industry. He switched his career path from preclinical to clinical research more than 12 years ago while working at Merck. He has extensive hands-on working experiences in Phase 1, 2 and 3 clinical trials with both small molecules and biologic drug candidates, and has successfully managed several global clinical trials in metabolic disease and oncology areas while working at Merck, BMS, and Eli Lilly.

 

Frank received his Bachelor and Master degrees in pharmaceutical sciences from Shanghai Medical University and earned his Pharm.D. degree from Shenandoah University.

Jianming Jimmy Hao (郝建明), PhD, JD

Attorney at Law and registered US Patent Attorney, Intellectual Property (IP) Department, Fox Rothschild LLP

Mr. Hao is an attorney at law and registered U.S. patent attorney with the Intellectual Property (IP) department of Fox Rothschild LLP, a prominent national general practice law firm. With more than a decade of legal experience, he serves as counsel to many clients including Fortune 100 companies, startups, entrepreneurs, investors, and academic institutions in biotechnology and pharmaceutical industries on a broad range of business and legal issues, including patent, trademark, licensing, litigation, VC financing, and M&A. He has prosecuted thousands of patent applications nationally and internationally, including portfolios that resulted in over $47 million venture financing and $51.5 million acquisition.

Mr. Hao has provided legal representation to several notable business transactions, including Alexion Pharmaceuticals Inc.’s acquisition of Synageva BioPharma Corp (valued at $8.4 billion), Humanwell Healthcare Group and PuraCap Pharmaceutical’s acquisition of Epic Pharma (valued at $550 million), BMS’s acquisition of Amira Pharmaceuticals (valued at $475 million), licensing and collaboration deals involving companies including Merck, Alnylam, and others.

Mr. Hao received a JD from Boston College Law School, a PhD from Columbia University, an MBA from Cornell University, and a BS from Nankai University. Prior to his legal career, he conducted research on neural and heart development at Columbia University as a graduate student. During his time at Columbia University, his PhD thesis was awarded With Distinction. He later held a postdoctoral fellowship at Harvard Medical School where he conducted research on oncology, immunology, and stem cells.

Guanghui Hu, Ph.D.President & CEO, Admera Health

Dr. Guanghui Hu is the President and co-founder of Admera Health. Previously, Dr. Hu served as Vice President and Global Business Leader of Translational Genomics at GENEWIZ, Inc. Prior to joining GENEWIZ, Inc., Dr. Hu acquired over 12 years of drug development and management experience in the pharmaceutical industry at companies including Merck and GlaxoSmithKline. Dr. Hu completed postdoctoral research at the University of California Los Angeles after earning his Ph.D. from Baylor College of Medicine, holds a Master of Science degree from the Chinese Academy of Sciences, and a Bachelor of Science degree from Tsinghua University. Dr. Hu is also a member of the American Society of Clinical Oncology.

Mike Hu, Ph. D.

Senior Director

Clinical Development, Jazz Pharmaceuticals

Dr. Mike Hu, Ph.D., has over 17 years of experience in clinical and pre-clinical R&D of drugs in multiple therapeutic areas: oncology, hematology, endocrinology, metabolic, viral, and rare diseases. Dr. Hu is Senior Director at Jazz Pharmaceuticals, Clinical Development, Hematology & Oncology at Ewing, NJ, since September 2016. Prior to joining Jazz, he was Director at Novartis Oncology, Clinical Pharmacology, Global Clinical Development & Medical Affairs at East Hanover, NJ. In the past 10 years from 2006 to 2016 at Novartis Oncology, Dr. Hu contributed to 6 drugs’ full clinical development, 6 global submissions/approvals, and 11 on-market drugs’ life cycle management with multiple billion-dollar franchises. Dr. Hu was involved in hundreds of clinical trials from Phase I, II, III to IV stages. He took management and leadership roles at Clinical Pharmacology Department, Global Project Teams, Oncology Protocol Review Committee, and other forums. He was receipt of Novartis President Award, Vision Award, Global Product Strategy Business Excellence Award, and Passion/Quality/Speed Award for many times. Before joining Novartis, Dr. Hu was Principal Scientist at GSK (GlaxoSmithKline), Metabolic & Viral, Drug Metabolism & Pharmacokinetics, Center of Excellence for Drug Discovery at Research Triangle Park, NC, from 2004 to 2006. He contributed to 2 drug candidates from early discovery, candidate selection to IND stage. Before joining pharmaceutical industry, Dr. Hu was postdoctor and Research Fellow at Yale University School of Medicine, Roswell Park Cancer Institute, and State University of New York at Buffalo, with focus on molecular pharmacology, biochemistry, pharmacokinetics, pharmacodynamics, drug metabolism and transporter in oncology drugs. He received Bachelor in Pharmacy and Ph.D. in Pharmaceutical Sciences at Shenyang Pharmaceutical University, China, with international exchange program at University of Tokyo, Japan. Dr. Hu has authored 51 peer-reviewed papers, 30 congress abstracts, 5 patents, 2 proceedings, and 1 book chapter. Before joining industry, he served as editor board for 4 journals, peer reviewer for >30 journals, and consultant for 2 medical groups.

Jerry Li, Ph.D.

Associate Principal Scientist

Global Clinical Development

Merck & Co, Inc.

Dr. Jerry Li is currently focused on late phase (Phase 2 and 3) clinical trials at Biostatistics and Research Decision Sciences (BARDS) within Global Clinical Development (GCD), Merck. Dr. Li obtained his Ph.D. degree in Statistics from University of Maryland, College Park.  Dr. Li joined Merck in 2013 following two years at Center for Drug Evaluation and Research (CDER), FDA.  At Merck Dr. Li has provided critical support for clinical trial design, protocol development, statistical analysis, trial monitoring as well as authoring clinical study report (CSR) and common technical documents (CTD) for new drug application (NDA) filing to regulatory agencies worldwide including U.S. FDA and European Medicines Agency (EMA). His expertise covers multiple therapeutic areas including oncology, infectious diseases, immunology and neurosciences. Several NDAs have been approved under Dr. Li’s lead and support. Some of them were delivered under extremely tight timelines. Dr. Li has published numerous peer-reviewed articles in both discovery and clinical areas. Dr. Li holds a Ph.D. degree in molecular cell biology. Dr. Li is currently a member of 2016-2017 Executive Council of Sino-American Pharmaceutical Professionals Association (SAPA).

Jian Liu (刘建), Ph. D.

Principal Scientist

External Discovery Chemistry, Merck

Dr. Jian Liu obtained a Ph.D degree in organic chemistry from UCLA in 1998 and did postdoctoral researches afterwards at UC Irvine and University of Pennsylvania. He joined the medicinal chemistry department in Merck Research Laboratory at Rahway site in Feb, 2001. Dr. Liu has worked on and managed projects on target validation, lead identification, and lead optimization and have generated multiple clinical candidates which went into first in man, phase I, and phase II clinical trials. Dr. Liu is an expert in drug discovery for many therapeutic areas such as osteoporosis, obesity, diabetes, cardiovascular disease, rheumatoid arthritis, oncology and infection disease.  Dr. Liu has also been in charge of outsourcing effort with several external companies. Based on his research work, Dr. Liu has published over 70 peer reviewed papers, patents and patent applications. Dr. Liu had worked as a lecturer at Tsinghua University for four years before he moved to the US. He is currently the 2016-2017 president-elect of Sino-American Pharmaceutical Professionals Assoication (SAPA), He has been an executive member of SAPA during the past three years, as the director of SAPA Career Development and Continuing Education committee in 2014-15 and the director of Bussiness Development and Service Department in 2015-16. He was the chair for 2015 SAPA Career Development Workshop and 2016 SAPA Scientific Symposium.

John Sun (孙壮), PhD, MBA, PMP

Global Project Manager, Global Development Operations, Novartis

John is a passionate career planning and development practitioner and advocate. He is the Global Project Manager of Global Development Operations at Novartis. Other than his responsibilities at work, John is an active volunteer in various professional organizations, including SAPA Executive Council Member, Chair of DIA Project Management Community, and Chair of Chinese Culture Community at Novartis. He had also served as Vice-President of Novartis Toastmasters Club and the Area Director of Toastmasters International.  John had presented in various domestic and international symposia on project management and drug development.

Previously John served as Global Program Team Director in the Established Medicines Development Franchise at Novartis. Before joining Novartis, John holds positions of project management and pharmaceutical research with increased responsibilities from Whitehall-Robins, Kos Pharmaceuticals, Schering-Plough, and Sanofi-Aventis. John obtained his PhD in pharmaceutics from the Virginia Commonwealth University, MBA from the Rutgers University, and BMed from the Beijing University of Chinese Medicine. John is a certified Project Management Professional (PMP).

Bing Yuan, PhD, MBA

Executive Director and Global Lead

Oncology Business Development, Merck

 

Dr. Bing Yuan is an oncology business executive experienced in business development, new product strategy, global product launch and brand life cycle management. At various stages, he made key contributions to 7 oncology drugs: Keytruda, Glivec, Afinitor, Jakavi, Zykadia, Halaven and Lenvima. Dr. Yuan is currently Executive Director and Global Lead, Oncology Business Development at Merck. He is in charge of worldwide search and evaluation of clinical stage Oncology assets. In particular, he focuses on expanding Merck’s portfolio in cancer immunotherapy and strengthens Keytruda’s market position in anti-PD1 /PD-L1 class.

Before joining Merck, he held various global commercial positions with increasing responsibilities at Novartis Oncology, most recently as Executive Director and Head, Life Cycle Strategy for Glivec and Afinitor. His other roles included new product planning, early portfolio strategy, and BD evaluation. He participated in global launch of Zykadia in lung cancer and was a core deal team member that successfully in-licensed Jakavi. He was three-time Novartis Oncology President Award recipient. Before joining Novartis, he was global strategic marketing lead for Eisai’s entire Oncology portfolio. Dr. Yuan holds a BS in Biochemistry from Nanjing University, a Ph.D. in Molecular Biology from Columbia University and a MBA from Cornell University.

山东省高校人才招聘会

时间:2016年10月21日周五17:00-19:00pm

地点:The Thomas Laboratory Room 003, The Thomas Building

内容安排:

1. 山东省教育厅领导宣讲国家及山东省海外人才引进政策、人才战略计划;

2. 青岛大学人力资源处负责人介绍青岛大学人才政策及急需重点引进人才的学科领域、专业以及相关生活与工作待遇;

3. 青岛大学药学院院长、首席教授介绍青岛大学的药学、新药研发和生物医学等领域的人才需求专业,现有科研支撑平台和技术能力,未来发展战略和举措;

4. 自由交流。

热烈欢迎教师、博士后、研究生踊跃参加

(招聘会场外提供三明治和饮料等)

中国科大代表团纽约英才招募 (2016.10.2)

2016.10.1-10.4,中国科大代表团将访问纽约等美东城市,进行人才招聘。访问团专题网站请见:http://usa.ustc.edu.cn。专题网站内容包括但不限于访问团成员组成、行程安排、中国科大人才招聘层次、待遇,众多海归心经,分享他们在中国科大工作生活的经历经验。

10月2日中国科大纽约学者宣讲会通知与报名:

http://www.ustcif.org/default.php/content/3090。

欢迎所有有海归意向的学者出席,了解中国科大人才招聘政策。

【纽约学者宣讲会】

时间:2016年10月2日,15:15-17:00

地点:Hyatt Regency Jersey City on the Hudson(会议室:Harborside I, II.)

费用:不收取费用。

餐饮:组织者将为出席学者提供饮料(咖啡或茶)。

2016年波士顿咨询公司(BCG)大中华区招聘信息介绍会

2016 BCG Greater China Recruiting Information Session

Princeton, Philadelphia, New Haven,
New York, Chicago, Los Angeles
Summer 2016

The Boston Consulting Group (BCG) is a leading global management consulting firm. We help our clients – private sector companies, governments, and NGOs – solve critical, challenging problems. With 85 offices in 48 countries, we are growing faster than our key competitors in every region.

BCG is actively looking for Chinese talents around the globe. We would like to invite you to our Greater China recruiting information session. This presentation will be a good opportunity for you to find out more about the fascinating and high impact work we do in Greater China as well as to discuss a career in management consulting in general terms.

Presenter:
Dr. Xinyi Wu, Senior Partner and Managing Director, Head of Recruiting & Head of People Team for Greater China

Please click below links for registration:

8th July (Fri), 6:00pm-7:30pm, Princeton

We are looking for candidates who are fluent in speaking Mandarin, and reading and writing Chinese to join our practice. The information sessions will be presented in Mandarin Chinese.

For full-time position of Class 2017 with Greater China system, please submit your application online at www.bcg.com/careers/apply. Please indicate Greater China offices as first priority in geographic preference, i.e. Beijing, Shanghai, Hong Kong and Taipei.

Kindly submit your application before the deadlines:
1) Doctoral degree full-time: 24th July 2016
2) MBA full-time: 23rd September 2016, if your school does not specify
3) Other degree full-time: 23rd September 2016, if your school does not specify

Visit us at www.bcg.com.cn or contact us at REC.GC@bcg.com for enquiries.

国家优秀自费留学生奖学金项目

为体现国家对广大自费留学生的关怀,奖励优秀自费留学人员在学业上取得的优异成绩,鼓励他们回国工作或以多种形式为国服务,国家留学基金管理委员会于2003年设立了“国家优秀自费留学生奖学金”(以下简称“自费生奖学金”),截至2015年,全球共有4914名优秀自费留学人员获奖。为做好纽约领区2016年自费生奖学金报名及评选工作,现就有关事宜通知如下:
一、报名及材料寄达时间
网上申报时间:北京时间5月20日0时至7月10日24时;
网上申报材料打印版(一份)寄达截止时间:美国东部时间7月18日12时;
申报材料电子版发送要求:将所有申报材料以PDF格式于7月15日24时之前发送至zgzfjxj@gmail.com,文件名为:申请人姓名+就读学校+专业,例如:张三+纽约大学+电子工程。

二、报名条件
1. 所在学校属于纽约领区,包括康涅狄格州、缅因州、马萨诸塞州、新罕布什尔州、新泽西州、纽约州、俄亥俄州、宾夕法尼亚州、罗得岛州、佛蒙特州等十个州;
2. 持有中华人民共和国有效护照,报名时年龄在40周岁以下;
3. 攻读博士学位一年以上(不含一年)的自费留学人员;
4. 不受理曾获得该奖学金、享受过或正在享受国家留学基金资助,以及2016年1月1日前已获得博士学位人员的申请。

三、奖励方式
获奖证书和现金。奖励金额为6000美元,特别优秀奖10000美元。

四、实施办法
为体现“公开、公正、公平”原则,奖学金评选工作严格按照“个人申请,国外初审,网上公示,国内终审,网上公布”的程序,采取国外限额推荐,国内差额评审的办法。
国家留学基金委将组织各学科领域专家组成专家评审委员会,差额评出获奖者。特别优秀奖由国内评审专家在终审环节中根据申请人综合素质进行评选。

五、申请方式
请申请人登陆“国家优秀自费留学生奖学金管理系统”(http://yxzfs.csc.edu.cn)进行网上报名,按要求将申请材料扫描上传至管理系统。
同时,请申请人向中国驻纽约总领馆教育组提交一份书面材料和一份电子版材料。材料清单详见《2016年“国家优秀自费留学生奖学金”申请注意事项》。

六、申请材料及填报要求
必须提交材料包括:
1.《国家优秀自费留学生奖学金申请表》(需附照片)
申请人需先登录网上报名系统(http://yxzfs.csc.edu.cn),按要求如实填写网上申请表、上传材料并确认无误后,可按系统提示完成网上提交、打印并本人签字。申请表中的有关栏目应视实际情况和项目要求进行填写,如无相关情况可不填(如工作经历)。申请人提交的书面申请表应与网上报名信息内容一致。网上申请表正式提交后不能再修改。
2. 护照首页复印件
护照须在有效期内。
3. 导师推荐信
请确保导师本人在推荐信上亲笔签字,电子签名视为无效签名。
如导师推荐信为非英语的其他语种,请翻译成汉语。
如导师亲自从网上提交的,请附单页说明:含导师姓名、被推荐人姓名等简要信息。同时,请导师将推荐信原件密封好,附在纸质材料中邮寄至总领馆教育组。
4.博士研究生在读院校开具的注册证明、学习有效证明
I-20表格不能作为在读证明使用。
在读院校注册证明应明确学习起止时间,预计答辩时间。如在读院校注册证明为非英语的其他语种,请翻译成汉语。
5. 最高学历、学位证书复印件
6.研究课题
选择性提交材料包括:
7. 代表性成果材料
两份代表性成果的封面、目录、首页等材料,以及1000字以内的中文摘要。
8. 学术会议邀请函
9. 本人认为有必要提供的其他材料
其他要求:
10. 装订要求:请按以上顺序将所有材料打印一套,在左上角用曲别针固定,如材料过厚可用长尾夹固定,请勿使用订书机装订。
11.重要说明
国内终审实行网上评审,请务必按要求上传电子材料。材料不全、上传材料错误或材料不能按时寄达将影响评审结果。请将以上申请材料邮寄至驻纽约总领馆教育组,供初审及存档用。

七、申请材料邮寄
本次申请不接受当面递交材料,请申请人通过快递或邮寄方式递交,并在信封上注明“自费生奖学金”。申请材料请务必于7月18日中午12时之前寄达我组,逾期寄达可能会导致无法参加评审。
邮寄地址:
Mr. Zhang Yang,Education Office, Chinese Consulate General in New York, 520 12th Avenue, New York, NY 10036
请申请人注意,申请材料恕不退还,请自留底稿。

八、欲了解更多信息,请查询自费生奖学金网站:http://yxzfs.csc.edu.cn。

附件:1.附件1:2016年“国家优秀自费留学生奖学金”实施细则
2.附件2:2016年“国家优秀自费留学生奖学金”申请注意事项
3.附件3:2016年“国家优秀自费留学生奖学金管理系统”使用指南

驻纽约总领馆教育组
2016年5月9日

第十一届“春晖杯”中国留学人员创新创业大赛北美赛区(纽约领区)赛事安排

◆ 网上报名:2016年4月22日至7月31日,驻纽约总领馆教育组和协办单位宣传、动员、培训和项目征集阶段,参赛者准备和撰写商业计划书。
◆ 专家评审:2016年9月“春晖杯”创业大赛组委会在国内组织专家对参赛项目进行评审;确定入围项目;进行为期7天的公示。
◆ 项目评奖:纽约领区入围项目将评选出一、二等奖若干。
◆ 颁奖仪式及项目对接大会:2016年10月28日(暂定),中国驻纽约总领事馆将为获得北美赛区(纽约领区)一、二等奖的入围项目颁奖,并邀请国内高新技术开发区、留学人员创业园、大学科技园、风险投资机构和企业以及其他用人单位代表参加,打造项目对接、人才洽谈和科技合作三位一体平台。
◆ 回国参加相关活动:2016年12月中下旬,中国驻纽约总领事馆教育组将组织北美赛区(纽约领区)所有入围项目代表赴广州参加“春晖杯”创业大赛颁奖典礼和大型对接活动,参加中国留学人员广州科技交流会,到国内相关地区进行项目落地考察、对接洽谈活动。
◆ “春晖杯”创业大赛北美赛区(纽约领区)联系人:中国驻纽约总领事馆教育组王文华,电话:(212)244-9392 转 8007,电子邮箱:whwang1618@gmail.com
敬请大家关注驻纽约总领馆微信平台:chinaconsulate_ny

报名须知
◆ 报名参赛者为目前在外学习或工作、取得硕士及以上学位、具有回国创新创业项目的中国留学人员;每位参赛者限报一个项目。正在或曾在美国、加拿大学习或工作的中国留学人员(含已获得美国、加拿大国籍或长期、永久居留证件以及港澳台地区的留学人员)均可报名。
◆ 无论希望在国内任何地方创业,均可报名。
◆ 请在报名网站首页选择“北美赛区”填写相关信息。
◆ 在线报名及信息查询网址:http://cyds.cscse.edu.cn。
◆ 对报名参赛者不收取任何费用。

参赛项目要求
◆ 具有较高创新水平和较强市场竞争力以及较好的潜在经济效益和社会效益。
◆ 具有高技术、高附加值、节能降耗、有利环境保护的科技创新项目或创意。行业领域可划分为:电子信息;生物、医药;资源与环境;光机电一体化;新材料;新能源与高效节能;科技农业;现代服务业、文化创意及其他高新技术领域。

参赛项目评审
◆所有北美赛区的参赛项目均参加“春晖杯”创业大赛组委会在国内统一组织的专家评审。
◆评审标准以是否具备创业的可行性为主;
◆评审委员会由来自科技开发区、留学人员创业园、大学科技园、风险投资机构和企业等方面的专家组成。
◆通过专家评审的入围项目将由“春晖杯”创业大赛组委会统一向社会公示。

2016浙江省海外高层次人才项目对接活动 – 纽约站

旅美科协

为推进浙江经济转型升级,推动浙江战略性新兴产业发展和传统产业升级,宣传、推介浙江的经济社会发展情况和留学人员创新创业环境,发布浙江省引进海外高层次人才、科技项目和外国专家需求信息,2016浙江(美国)海外高层次人才洽谈会将于5月21日和22日分别在美国硅谷和纽约举办。此次活动,将有130多家人才创业平台、知名企业、高校科研院所等单位,携带1500多个人才岗位需求和80多个项目合作需求来美洽谈。热诚欢迎在大纽约地区工作、学习的高层次人才踊跃参会,共谋发展!

 

一、活动主办单位、内容

主办单位:浙江省人才工作办公室、浙江省人力资源和社会保障厅、浙江省人民政府外事侨务办公室

协办单位:旅美科技协会

主要活动:宣传、推介浙江的经济社会发展情况和留学人员创新创业环境;发布浙江省引进海外高层次人才、科技项目和外国专家需求信息;现场交流、对接洽谈等。

 

二、预知具体项目详情(如下)请登陆链接进行下载

http://goo.gl/7IWxxi

三、纽约地区活动时间、地点

时间:2016年5月22日,星期日,2:00pm-6:00pm

地点:新泽西州萨默塞特双树酒店会议中心(Double Tree Hotel,Somerset,NJ)

地址:200 Atrium Drive, Somerset, NJ 08873

(或登陆链接 http://goo.gl/7IWxxi 查询详细开车指南)

注册:请复制并粘贴此链接至您的网页浏览器

http://castusa-gny.org/node/25

入场免费,停车免费


中国旅美科技协会大纽约分会(CAST-GNY)

中国旅美科技协会(CAST-USA)是1992年夏在纽约注册成立的非盈利性组织,其三大宗旨是:促进中美之间文化、科技、教育、经贸等领域的交流与合作;弘扬中国传统文化、促进中美两国人民的相互了解,加强旅美学人、华人专业人士之间的团结、合作与交流。旅美科协是一个跨地区(美国)、跨行业的综合性科技团体,会员主要由来自科技、文化、教育、法律、金融、人文等各个领域的中国旅美专业人士组成,分布在全美几十个州的十几个旅美科协分会及专业学会。

网站:http://castusa-gny.org/

华谊资本 – Financial Analyst招聘信息

华谊兄弟

华谊资本海外招聘啦!以下为 Financial Analyst 招聘信息,有意者请发送简历及两张照片到 hr@asiastartalent.org,具体申请方式请见页底。

Job Title: Financial Analyst

Job Categories: Finance/Accounting, Full /Part-time, Temp-to-hire

Summary: The entry-level Financial Analyst will work with the Investment Management team to provide precise analysis efforts and assist team with underwriting.

Company Profile

Huayi Brothers Media Group is a publicly listed filmed entertainment company in China, established in 1994. It is primarily engaged in film and television production and distribution. The company works for artist development, music production and offline music distribution. It also provides talent management and advertising services in the industry. As a leader of this talent-driven industry, the Huayi Brothers success is based on its deep commitment to forming cooperative partnerships and putting the needs of its people first. Since being listed on ChiNext in 2009, the company has served as the global ambassador for Chinese pop culture by expanding its business up the industry chain. Today Huayi Brothers not only does content production, it has also built new distribution channels (such asself-owned cinemas) and invested deeply in derivative businesses based on original IP, including cultural tourism, video games, location-based entertainment and more, This ambitious goal will reshape how the world sees Chinese entertainment, aligning with Huayi Brothers’ mission to “touch the hearts of audiences” in China and abroad through meaningful, entertaining, and unforgettable works of art.

Essential Functions of Position:

The position requires maintaining financial models (dashboards) and providing business analysis to management for business decisions. Strong analytical skills are required and ability to formulate key insights from various data sources and systems is also required. The position requires solid interpersonal andcommunication skills due to the collaboration with across functional teams, across HY Bro business units and interaction with the leadership team.

Job Responsibilities

  • Develop key analytics and reporting from various sources of data across HY Bro andeffectively summarize financial data
  • Maintain forecast models supporting the various vendor deals and provides key varianceanalysis
  • Manipulatesand reports on large volumes of data primarily using excel and other datamodeling software
  • Leveragesall internal software applications to increase efficiency and effectiveness offorecasting and analysis, is expected to have a detailed knowledge of applications used e.g. GATOR, SAP and PSL/Vista
  • Preparead-hoc reports, analysis, and conduct special project as necessary
  • Assist HY Bro Partners or Managing Director on client engagements to:
    • Create financial modeling/projections including 13 week cash flows and budgets
    • Analyze client financial records and prepare findings
    • Participate in the drafting client presentation
    • Additional support or tasks as necessary
  • Analyze and identify trends in past and present financial and operational data gathered from client financial and operational software packages
  • Review, trouble shoot and make recommendations to improve financial processes. Interact with client management and staff and create reports to present findings

Qualifications

  • Undergraduate degree in Finance, Economics, Accounting, Engineering, Media preferred for summer internships. Master degree required, or working towards a MBA/PhD degree for full-time positions. Candidates holding other degrees who demonstrate strong finance interests are welcomed as well
  • CFA, CAIA or other industry licenses/designations preferred
  • Demonstrated experience in developing cash flow models
  • Familiarity with financial statement analysis, budgeting, and benchmarking
  • Strong Excel and Access skills (including V-Lookups, Pivot Tables, Macros, reportwriting)
  • Excellent analytical and problem-solving skills
  • Ability to manage multiple projects and work under strict and/or competing deadlines and priorities
  • Proactive communicator with team members, colleagues, client management
  • Willingness to travel regionally 40-60% and to maintain a flexible schedule in a fast-paced, constantly changing and due-date focused environment

Employment details

  • Employment type: Full-time/summer internship
  • Work location: Hong Kong, New York, Beijing, Shanghai
  • Start date: Flexible
  • Compensation: Highly competitive, negotiable

Application

For interested applicants, please send your resume along with two photos to hr@asiastartalent.org with the following subject: [First name,Last name], [University], [Company], [Position applying for].

药明康德新药开发有限公司普林斯顿招聘宣讲会及面试

Poster

2016年6月14日,药明康德新药开发有限公司(www.wuxiapptec.com)将在普林斯顿大学举办招聘宣讲会及面试,招聘目标为化学专业、药学专业及相关专业博士或博士后。具体信息如下:

地点:Friend Center 004

时间:2016年6月14日4PM - 6PM(4PM-5PM Career Talk, 5PM-6PM Interview)

要求:有意向同学请携带简历及研究小结

RSVP:http://goo.gl/forms/3gdw1mVtwy

公司招募公告:请点击